TC
BMRN icon

TownSquare Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History

TownSquare Capital’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,501
Closed -$296K – 1690
2024
Q4 		$296K Buy
+4,501
New +$301K ﹤0.01% 1256
2024
Q3 		– Sell
-6,344
Closed -$522K – 1490
2024
Q2 		$522K Buy
6,344
+1,837
+41% +$153K 0.01% 867
2024
Q1 		$394K Sell
4,507
-28
-0.6% -$2.51K 0.01% 915
2023
Q4 		$437K Sell
4,535
-215
-5% -$19K 0.01% 816
2023
Q3 		$420K Buy
+4,750
New +$423K 0.01% 813

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TownSquare Capital's BMRN Position: Q1 2025 in Review

TownSquare Capital sold out of BioMarin Pharmaceuticals (BMRN) in Q1 2025, closing a stake of 4,501 shares — an estimated $296K sold.

TownSquare Capital first reported a position in BMRN in Q3 2023 and held it in 5 quarters. The position peaked at $522K in Q2 2024. 584 funds tracked by Wall St. Rank hold BMRN as of Q1 2025.

  • TownSquare Capital reported no remaining BioMarin Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • TownSquare Capital sold 4,501 BioMarin Pharmaceuticals shares in Q1 2025, an estimated $296K.
  • TownSquare Capital first reported a position in BioMarin Pharmaceuticals in Q3 2023 and held it in 5 quarters.
  • TownSquare Capital's BioMarin Pharmaceuticals position peaked at $522K in Q2 2024.
  • 584 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2025.

Based on TownSquare Capital's 13F filing for Q1 2025, filed 12 May 2025.